Phase I Study of Adjuvant Immunotherapy with Autologous Tumor-Infiltrating Lymphocytes in Locally Advanced Cervical Cancer

Tumor-infiltrating lymphocyte-based adoptive cell therapy following concurrent chemoradiotherapy was safe in an academic center setting, with potential effective responses in locally advanced cervical cancer patients.